Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment [Phase 1]
Phase 1 trial to assess the safety of the anti-cancer drugs tazemetostat and belinostat in patients with recurrent or refractory lymphomas; …
-
CLINICAL_TRIALS trial_result · 2026-02-25Clinical Trial Update: A Phase I/II Study of ASTX660 in Patients With Relapsed or Refractory T-cell Lymphoma [Phase 1, Phase 2]
Phase I/II study of ASTX660 in relapsed or refractory T-cell lymphomas has been terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light [Phase 2]
Phase 2 trial evaluating hypericin ointment with visible light for mycosis fungoides has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers [Phase 1]
A Phase 1 safety study of PF-08046045/SGN-35T sponsored by Seagen has been terminated in adults with advanced lymphomas and Hodgkin disease.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: SGN-35 in CD30-positive Lymphoproliferative Disorders (ALCL), Mycosis Fungoides (MF), and Extensive Lymphomatoid Papulosis (LyP) [Phase 2]
Phase 2 clinical trial update for brentuximab vedotin (SGN-35) in CD30-positive lymphoproliferative disorders, including primary cutaneous a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Study of Pembrolizumab (MK-3475) in Combination With Romidepsin [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating pembrolizumab in combination with romidepsin for recurrent or refractory T-cell lymphomas; the study i…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma
A real-world study reports on the use of mogamulizumab for treating cutaneous T-cell lymphoma and its subtypes.
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) [EARLY_Phase 1]
A first-in-human Phase 1 dose-escalation study of DT-7012, a CCR8-targeting monoclonal antibody from Domain Therapeutics, in relapsed or ref…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Romidepsin Maintenance After Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 trial update on romidepsin as maintenance therapy after allogeneic stem cell transplantation. The study status is completed and incl…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma [Phase 4]
Phase 4 trial evaluating Brentuximab Vedotin in Chinese adults with CD30-positive cutaneous T-cell lymphoma has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL [Phase 2]
Phase 2 trial comparing HyBryte (synthetic hypericin) to Valchlor (mechlorethamine gel) for Cutaneous T-Cell Lymphoma/Mycosis Fungoides has …
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma [Phase 2]
A Phase 2 study evaluating brentuximab vedotin in combination with lenalidomide for stage IB-IVB relapsed or refractory T-cell lymphoma has …
-
CLINICAL_TRIALS trial_result · 2025-07-18Clinical Trial Update: Ritlecitinib in CTCL [Phase 2]
A Phase 2 trial of ritlecitinib for cutaneous T-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies [Phase 1]
Phase 1 trial evaluating a combination of romidepsin, CC-486 (oral azacitidine), dexamethasone, and lenalidomide (RAdR) for relapsed/refract…
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma [Phase 1]
A Phase 1 study evaluating the feasibility of combining romidepsin with brentuximab vedotin in cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of Yttrium-90 labeled basiliximab with combination chemotherapy before stem cell transplant for mature T-cell and NK-cell non-…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors [Phase 1]
Phase 1 trial of KT-333 in adults with refractory lymphomas and solid tumors reports safety, pharmacokinetics, pharmacodynamics, and prelimi…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
The study evaluating retreatment with Brentuximab Vedotin in adults with cutaneous T-cell lymphoma has completed. The clinical trial update …
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating E7777 for persistent and recurrent cutaneous T-cell lymphoma has completed. Results from the study have been post…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
This completed clinical trial (NCT01460914) reports outcomes of extracorporeal photopheresis treatment for cutaneous T-cell lymphoma and gra…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
A completed study update based on a Spanish medical-record review of adults with relapsed or refractory CD30+ malignancies who were re-treat…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Micro Needle Array-Doxorubicin (MNA-D) in Patients With Cutaneous T-cell Lymphoma (CTCL) [Phase 1]
Phase 1 study of Micro Needle Array-Doxorubicin (MNA-D) for Cutaneous T-cell Lymphoma has completed, evaluating a microneedle-based delivery…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies [Phase 1]
Tinostamustine, a first-in-class alkylating HDAC inhibitor fusion molecule, completed its Phase 1 study in relapsed/refractory hematologic m…
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab [Phase 2]
Phase 2 trial evaluating letermovir for prevention of cytomegalovirus reactivation in patients with hematologic malignancies treated with al…